IL33 and melanoma: MTS assays on 2D cultures confirmed that DAC exhibited dose-dependent anti-proliferative effects on both mouse B16.F10 (Supplementary Fig. 3 A) and human A375M (Supplementary Fig. 3B) melanoma cells independently of IL-33.